Nom : BOURGEOIS
Prénom : Nathalie
Equipe :
BioGEPPE
Grade : PH
Adresse email : Cette adresse e-mail est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser.
Téléphone : (+33) 4 67 63 27 51
Implantation : CHU Caremeau
Appartenance : UM
Publications :
|
Sasso M, Normand AC, Pantel A, Bourgeois N, Lachaud L (2018) Evaluation of the DiversiLab (r) automated repetitive sequence-based PCR system for the characterization of Candida albicans and Candida glabrata isolates. Journal De Mycologie Medicale 28: 320-326 doi |
|
Al-Yasiri MH, Normand AC, L'Ollivier C, Lachaud L, Bourgeois N, Rebaudet S, Piarroux R, Mauffrey JF, Ranque S (2016) Opportunistic fungal pathogen Candida glabrata circulates between humans and yellow-legged gulls. Scientific Reports 6: 36157 doi |
|
Sasso M, Chastang-Dumas E, Bastide S, Alonso S, Lechiche C, Bourgeois N, Lachaud L (2016) Performances of four real-time PCR assays for diagnosis of Pneumocystis jirovecii pneumonia. Journal of Clinical Microbiology 54: 625-630 doi |
|
Bourgeois N, Laurens C, Bertout S, Balard Y, Krasteva D, Rispail P & Lachaud L (2014) Assessment of caspofungin susceptibility of Candida glabrata by the Etest (R), CLSI, and EUCAST methods, and detection of FKS1 and FKS2 mutations. European Journal of Clinical Microbiology & Infectious Diseases. 33: 1247-1252 doi |
|
Lachaud L, Bourgeois N, Kuk N, Morelle C, Crobu L, Merlin G, Bastien P, Pagès M & Sterkers Y (2014) Constitutive mosaic aneuploidy is a unique genetic feature widespread in the Leishmania genus. Microbes and Infection. 16: 61-66 doi
|
|
Sterkers Y, Lachaud L, Bourgeois N, Crobu L, Bastien P & Pagès M (2012) Novel insights into genome plasticity in Eukaryotes: mosaic aneuploidy in Leishmania. Molecular Microbiology. 86: 15-23 doi |
|
Bourgeois N, Douard-Enault C, Reynes J, Lechiche C, Basset D, Rispail P & Lachaud L (2011) Seven imported histoplasmosis cases due to Histoplasma capsulatum var. capsulatum: From few weeks to more than three decades asymptomatic period. Journal de Mycologie Medicale. 21: 19-23 doi
|
|
Crouzet J, Sotto A, Picard E, Lachaud L & Bourgeois N (2011) A case of Candida haemulonii osteitis: clinical features, biochemical characteristics, and antifungal resistance profile. Clinical Microbiology and Infection. 17: 1068-1070 doi
|
|
Bourgeois N, Bastien P, Reynes J, Makinson A, Rouanet I & Lachaud L (2010) 'Active chronic visceral leishmaniasis' in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patients. HIV Medicine. 11: 670-673
|
|
Bourgeois N, Boutet A, Bousquet PJ, Basset D, Douard-Enault C, Charachon S & Lachaud L (2010) Comparison of three real-time PCR methods with blood smears and rapid diagnostic test in Plasmodium sp. infection. Clinical Microbiology and Infection. 16: 1305-1311 |
|
Bourgeois N, Dehandschoewercker L, Bertout S, Bousquet PJ, Rispail P & Lachaud L (2010) Antifungal Susceptibility of 205 Candida spp. Isolated primarily during invasive candidiasis and comparison of the Vitek 2 System with the CLSI broth microdilution and Etest methods. Journal of Clinical Microbiology. 48: 154-161 |
|
Casanova M, Crobu L, Blaineau C, Bourgeois N, Bastien P & Pagès M (2009) Microtubule-severing proteins are involved in flagellar length control and mitosis in Trypanosomatids. Molecular Microbiology. 71: 1353-1370 |
|
Lachaud L, Bourgeois N, Plourde M, Leprohon P, Bastien P & Ouellette M (2009) Parasite susceptibility to Amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV Type 1 and Leishmania infantum. Clinical Infectious Diseases. 48: E16-E22 |
|
Lachaud L, Calas O, Picot MC, Albaba S, Bourgeois N & Pratlong F (2009) Value of 2 IgG avidity commercial tests used alone or in association to date toxoplasmosis contamination. Diagnostic Microbiology and Infectious Disease. 64: 267-274 |
|
Bourgeois N, Lachaud L, Reynes J, Rouanet I, Mahamat A & Bastien P (2008) Long-term monitoring of visceral leishmaniasis in patients with AIDS - Relapse risk factors, value of polymerase chain reaction, and potential impact on secondary prophylaxis. Journal of Acquired Immune Deficiency Syndromes. 48: 13-19 |
